Showing 1 - 3 results of 3 for search 'Connor Frank', query time: 0.01s Refine Results
  1. 1
    Correction to “In Vitro and In Vivo Comparison of Random versus Site-Specific Conjugation of Bifunctional Chelating Agents to the CD33-Binding Antibody for Use in Alpha- and Beta-Radioimmunotherapy”

    Correction to “In Vitro and In Vivo Comparison of Random versus Site-Specific Conjugation of Bifunctional Chelating Agents to the CD33-Binding Antibody for Use in Alpha- and Beta-R... by Kevin J. H. Allen, Connor Frank, Rubin Jiao, Mackenzie E. Malo, Michele Bello, Laura De Nardo, Laura Meléndez-Alafort, Ekaterina Dadachova

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    In Vitro and In Vivo Comparison of Random versus Site-Specific Conjugation of Bifunctional Chelating Agents to the CD33-Binding Antibody for Use in Alpha- and Beta-Radioimmunotherapy

    In Vitro and In Vivo Comparison of Random versus Site-Specific Conjugation of Bifunctional Chelating Agents to the CD33-Binding Antibody for Use in Alpha- and Beta-Radioimmunothera... by Kevin J. H. Allen, Connor Frank, Rubin Jiao, Mackenzie E. Malo, Michele Bello, Laura De Nardo, Laura Meléndez-Alafort, Ekaterina Dadachova

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Fingolimod synergizes with anti-PD-1 radioimmunotherapy in an experimental multiple sclerosis model through enhanced lymph node retention and CD8+ T cell depletion

    Fingolimod synergizes with anti-PD-1 radioimmunotherapy in an experimental multiple sclerosis model through enhanced lymph node retention and CD8+ T cell depletion by Connor Frank, Kevin J. H. Allen, Wojciech Dawicki, Michael C. Levin, Michael C. Levin, Michael C. Levin, Michael C. Levin, Ekaterina Dadachova

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: